Urban One forecasts $40M 2026 adjusted EBITDA amid $20M annualized cost-savings plan
Topics: cost-savings plan EBITDA forecast financial guidance
Read the full article at Seeking Alpha
Part of the story CorMedix Reports Q3 2026 Results Amid DefenCath Pricing Transition and Heron Therapeutics Acquisition Plans (9 articles)